Swiss National Bank
COLL icon

Swiss National Bank’s Collegium Pharmaceutical COLL Stock Holding History

Swiss National Bank’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.06M Hold
62,300
– – ﹤0.01% 1838
2025
Q4 		$2.88M Hold
62,300
– – ﹤0.01% 1676
2025
Q3 		$2.18M Buy
62,300
+900
+1% +$31.3K ﹤0.01% 1817
2025
Q2 		$1.82M Sell
61,400
-1,100
-2% -$31.4K ﹤0.01% 1856
2025
Q1 		$1.87M Sell
62,500
-800
-1% -$24.4K ﹤0.01% 1807
2024
Q4 		$1.81M Sell
63,300
-600
-0.9% -$19.9K ﹤0.01% 1910
2024
Q3 		$2.47M Sell
63,900
-500
-0.8% -$17.8K ﹤0.01% 1739
2024
Q2 		$2.07M Hold
64,400
– – ﹤0.01% 1792
2024
Q1 		$2.5M Sell
64,400
-4,100
-6% -$143K ﹤0.01% 1720
2023
Q4 		$2.11M Sell
68,500
-7,600
-10% -$190K ﹤0.01% 1796
2023
Q3 		$1.7M Buy
76,100
+800
+1% +$18.2K ﹤0.01% 1942
2023
Q2 		$1.62M Buy
75,300
+6,400
+9% +$145K ﹤0.01% 2029
2023
Q1 		$1.65M Sell
68,900
-9,300
-12% -$247K ﹤0.01% 1955
2022
Q4 		$1.81M Buy
78,200
+800
+1% +$16.1K ﹤0.01% 1953
2022
Q3 		$1.24M Hold
77,400
– – ﹤0.01% 2210
2022
Q2 		$1.37M Buy
77,400
+3,800
+5% +$63.9K ﹤0.01% 2176
2022
Q1 		$1.5M Buy
73,600
+3,500
+5% +$66.1K ﹤0.01% 2198
2021
Q4 		$1.31M Hold
70,100
– – ﹤0.01% 2309
2021
Q3 		$1.38M Buy
70,100
+1,200
+2% +$25.9K ﹤0.01% 2264
2021
Q2 		$1.63M Sell
68,900
-2,200
-3% -$50.8K ﹤0.01% 2235
2021
Q1 		$1.69M Buy
71,100
+1,100
+2% +$26.1K ﹤0.01% 2105
2020
Q4 		$1.4M Hold
70,000
– – ﹤0.01% 2123
2020
Q3 		$1.46M Buy
70,000
+2,700
+4% +$48.7K ﹤0.01% 1875
2020
Q2 		$1.18M Buy
67,300
+15,300
+29% +$300K ﹤0.01% 2013
2020
Q1 		$849K Buy
52,000
+800
+2% +$16.5K ﹤0.01% 1923
2019
Q4 		$1.05M Buy
51,200
+1,600
+3% +$26.7K ﹤0.01% 2113
2019
Q3 		$569K Hold
49,600
– – ﹤0.01% 2317
2019
Q2 		$652K Buy
49,600
+8,500
+21% +$114K ﹤0.01% 2331
2019
Q1 		$622K Hold
41,100
– – ﹤0.01% 2298
2018
Q4 		$706K Buy
41,100
+3,100
+8% +$53K ﹤0.01% 2198
2018
Q3 		$560K Hold
38,000
– – ﹤0.01% 2379
2018
Q2 		$906K Hold
38,000
– – ﹤0.01% 2225
2018
Q1 		$971K Buy
38,000
+7,700
+25% +$183K ﹤0.01% 2091
2017
Q4 		$559K Hold
30,300
– – ﹤0.01% 2377
2017
Q3 		$318K Hold
30,300
– – ﹤0.01% 2475
2017
Q2 		$379K Hold
30,300
– – ﹤0.01% 2478
2017
Q1 		$305K Hold
30,300
– – ﹤0.01% 2483
2016
Q4 		$472K Buy
30,300
+12,400
+69% +$206K ﹤0.01% 2419
2016
Q3 		$345K Hold
17,900
– – ﹤0.01% 2453
2016
Q2 		$212K Buy
+17,900
New +$296K ﹤0.01% 2556

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Swiss National Bank's COLL Position: Q1 2026 in Review

Swiss National Bank held its Collegium Pharmaceutical (COLL) position steady in Q1 2026 at 62,300 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Swiss National Bank first reported a position in COLL in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.88M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Swiss National Bank held 62,300 shares of Collegium Pharmaceutical worth $2.06M as of Q1 2026.
  • Swiss National Bank left its Collegium Pharmaceutical share count unchanged in Q1 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1838 holding.
  • Swiss National Bank first reported a position in Collegium Pharmaceutical in Q2 2016 and has held it in 40 quarters since.
  • Swiss National Bank's Collegium Pharmaceutical position peaked at $2.88M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.